Details for Patent: RE46604
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent RE46604 protect, and when does it expire?
Patent RE46604 protects HETLIOZ and is included in one NDA.
This patent has one hundred and thirty-five patent family members in twenty-two countries.
Summary for Patent: RE46604
Title: | Treatment of circadian rhythm disorders |
Abstract: | Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm. |
Inventor(s): | Dressman; Marlene Michelle (Germantown, MD), Feeney; John Joseph (Olney, MD), Licamele; Louis William (Potomac, MD), Polymeropoulos; Mihael H. (Potomac, MD) |
Assignee: | VANDA PHARMACEUTICALS, INC. (Washington, DC) |
Application Number: | 15/051,978 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE46604 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent RE46604
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vanda Pharms Inc | HETLIOZ | tasimelteon | CAPSULE;ORAL | 205677-001 | Jan 31, 2014 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TREATMENT OF NON-24 HOUR SLEEP-WAKE DISORDER BY ORALLY ADMINISTERING 20MG OF TASIMELTEON ONCE DAILY BEFORE BEDTIME | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE46604
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013211878 | See Plans and Pricing | |||
Australia | 2013211880 | See Plans and Pricing | |||
Australia | 2013361459 | See Plans and Pricing | |||
Australia | 2015206797 | See Plans and Pricing | |||
Australia | 2016204178 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |